SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-065659
Filing Date
2017-12-14
Accepted
2017-12-14 16:07:28
Documents
1
Period of Report
2017-12-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4076
  Complete submission text file 0001209191-17-065659.txt   5431
Mailing Address 890 WINTER STREET WALTHAM MA 02451
Business Address
Bermingham Nessan (Reporting) CIK: 0001377759 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37766 | Film No.: 171256245

Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Issuer) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences